HB

H. Bosch

Botanix Pharmaceuticals Ltd | Non-Executive Director
Dr Bosch was involved in the development of SoluMatrix drug delivery technology, which has been used in four FDA-approved prescription drug products. Earlier in his career, he worked on the application of nanotechnology in pharmaceutical product development. In 1995, he co-founded NanoSystems and was a co-inventor of NanoCrystal Technology, which contributed to the development and FDA approval of seven prescription drug products across a range of indications and routes of administration.

Company and Role

Company
Title
Tenure
Since
BOT
Botanix Pharmaceuticals Ltd
  • Non-Executive Director
3yrs, 3mthJul 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
Botanix Pharmaceuticals Ltd
30/06/2621,503,369N/A1,666,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
Botanix Pharmaceuticals Ltd
20/04/26
Issued
1,666,667$0.035$58,333Placement
BOT
Botanix Pharmaceuticals Ltd
10/04/26
Issued
1,666,667$0.060$100,000Placement
BOT
Botanix Pharmaceuticals Ltd
02/12/24
Issued
3,000,000$0.350$1,050,000Issue of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Buy
500,000$0.085$42,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Exercise
500,000$0.085$42,500Conversion of securities